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Abstract
Background: The contents of pharmaceutical industry sponsored supplements to medical journals are perceived to be less
credible than the contents of their parent journals. It is unknown if their contents are cited as often. The objective of this
study was to quantify the citability of original research and reviews contained in supplements and compare it with that for
the parent journal.
Methodology/Principal Findings: This was a cohort study of 446 articles published in the Journal of Clinical Psychiatry (JCP)
and its supplements for calendar years 2000 and 2005. The total citation counts for each article up to October 5, 2009 were
retrieved from the ISI Web of Science database. The main outcome measure was the number of citations received by an
article since publication. Regular journal articles included 114 from calendar year 2000 and 190 from 2005. Articles from
supplements included 90 from 2000 and 52 from 2005. The median citation counts for the 3 years post-publication were 10
(interquartile range [IQR], 4–20), 14 (IQR, 8–20), 13.5 (IQR, 8–23), and 13.5 (IQR, 8–20), for the 2000 parent journal, 2000
supplements, 2005 parent journal, and 2005 supplements, respectively. Citation counts were higher for the articles in the
supplements than the parent journal for the cohorts from 2000 (p=.02), and no different for the year 2005 cohorts (p=.88).
The 2005 parent journal cohort had higher citation counts than the 2000 cohort (p=.007), in contrast to the supplements
where citation counts remained the same (p=.94).
Conclusions/Significance: Articles published in JCP supplements are robustly cited and thus can be influential in guiding
clinical and research practice, as well as shaping critical thinking. Because they are printed under the sponsorship of
commercial interests, they may be perceived as less than objective. A reasonable step to help improve this perception
would be to ensure that supplements are peer-reviewed in the same way as regular articles in the parent journal.
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Introduction
Supplements to biomedical journals can be used as a forum to
highlight a particular disease state or intervention. They are often
sponsored by a commercial enterprise with a stake in the topic
being discussed. For example the sponsor can be a pharmaceutical
company wishing to promote their medications. Usually the
supplement is funded through an unrestricted grant and CME
credits may or may not be provided. The fee charged for a
supplement is not usually made explicit, but a figure of $50,000 for
up to 60 pages has been publically noted for supplements to the
journal Chest [1]. Recommendations have been made regarding
the role of the journal editor, selection of a supplement editor,
disclosure of funding source, and the role of the funding
organization [2]. Individual journals have published their policies
and commentaries on this topic in editorials [1,3–8].
Although the peer review process (if any) often differs from that of
the parent journal (as will be described in our case example), it is not
unusualforthecontentsofthesejournalsupplementstobethemselves
cited in scholarly works. Controversy arises when the contents of the
supplementsareperceived tobe biased in favorofthe sponsor[9–20].
Thishasalsoledtospiriteddiscussionsintheinternet’s‘‘blogosphere’’
[21]. The topic of journal supplements has figured prominently in
testimony regarding promotional activities of pharmaceutical com-
panies [22]. Supplements at times are derived from ‘‘consensus
conferences’’ which some have opined is a form of drug promotion
[23]. In rare cases, distribution of supplements has been withheld
from certain subscribers because of drug regulatory concerns [24].
Although the quality of articles published in journal supple-
ments have been compared with the quality of those published in
the parent journal, as reported by Rochon and colleagues in 1994
[25], what remains unanswered is how often are articles in
supplements actually cited. The aim of this study is to contrast the
citation rates for articles appearing in the 2000 and 2005 issues of
the Journal of Clinical Psychiatry and its supplements, using
citation profiles in the ISI Web of Science database [26].
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The Journal of Clinical Psychiatry (JCP) was selected as the
prototypical biomedical journal that regularly publishes supple-
ments. JCP is a peer-reviewed psychiatry specialty journal
published monthly by Physicians Postgraduate Press, Inc. [27].
JCP is the official publication of the American Society of Clinical
Psychopharmacology [28] and is provided to its members as a
benefit; however the only regular content that is directly
attributable to activities of this society is a column, the ‘‘ASCP
Corner.’’ According to JCP’s information for media planners [29],
the journal has 35,613 subscribers and is the 3rd most cited
psychiatric journal in the world with a journal impact factor of
5.533 as of December 2008, and ranks highest in the mean total
number of office- and hospital-based issue readers of psychiatric
journals according to a June 2008 FocusH Readership Study. Most
subscribers receive the journal free of charge if they are designated
as psychiatric clinicians in provider databases such as the
American Medical Association’s Masterfile. Reprints of individual
articles and supplements can also be widely distributed as part of
marketing and informational campaigns conducted by the
pharmaceutical industry. JCP’s masthead reads ‘‘Our primary
mission is to provide lifelong learning for the physician through
evidence-based, peer-reviewed scientific information about the
diagnosis and treatment of behavioral health and neuropsychiatric
disorders’’ [30]. Articles in the parent journal are a mixture of
research reports, including reports of randomized controlled trials,
and reviews. Articles in the supplements are usually reviews.
Articles are indexed in MEDLINE/PubMed, EMBASE/Excerpta
Medica, Psychological Abstracts, Current Contents, Science
Citation Index, Hospital Literature Index, Biological Abstracts,
Cumulative Index to Nursing and Allied Health Literature,
International Nursing, PsycINFO, Chemical Abstracts, Adolescent
Mental Health Abstracts, Alcohol and Alcohol Science Problems
Database, and the Social Sciences Citation Index. Papers
submitted to JCP undergo the usual and customary peer review
process by expert consultants [31], i.e., typically two or more
independent reviewers are charged with examining the quality of
the study or review and its potential importance to the field.
Supplements to JCP undergo a different review process as
disclosed in the supplement, and include a planning session
(telephone or live) at which the authors have the opportunity to
comment on each other’s presentations/submissions, a prepubli-
cation review by the pre-designated Chair of the activity for
accuracy and fair balance (the Chair often writing an introduction
as well as one or more articles in the supplement), and a
prepublication review for fair balance by a reviewer from the
CME Institute of Physicians Postgraduate Press, Inc [32]. The role
of the journal editor in the production of the supplement is not
explicitly stated.
The tables of contents for the JCP issues from calendar years
2000 and 2005, including supplements, were obtained electron-
ically from the JCP Web site [27]. Four cohorts of articles were
identified: JCP articles from 2000, JCP supplement articles from
2000, JCP articles from 2005, and JCP supplement articles from
2005. Included were all articles in the parent journal or
supplement for which an on-line abstract is available; excluded
from further consideration were publisher’s notes, editorials,
commentaries, introductions to special sections, letters to the
editor, columns, book reviews, or any other items not accompa-
nied by an on-line abstract. Excluded from further consideration
from the supplements were any introductory or concluding
remarks or discussion for which an on-line abstract is not
available. The numbers of citations to the included articles (citable
articles) were determined by querying the ISI Web of Science
database [26] for January 1, 2000 through October 5, 2009 for the
articles published in 2000, and for January 1, 2005 through
October 5, 2009 for the articles published in 2005. The ISI
database captures citations from scholarly journals, books, book
series, reports, and conference proceedings. No constraints were
used. No sample size calculation was made prior to the data
extraction. Mean, median, and range of number of citations for
each cohort of articles were calculated.
The citation counts for each cohort are described using
summary statistics. Compared were the number of citations for
the parent journal versus its supplements for the first 3 complete
calendar years post-publication, i.e. 2001 through 2003 for the
2000 cohorts and 2006 through 2008 for the 2005 cohorts. Also
compared were the 2000 versus the 2005 cohorts to detect any
possible changes in citation counts. Because citation counts do not
follow a Gaussian distribution and the sample size is small
(particularly for the 2005 supplement cohort), nonparametric
testing using the two independent samples Wilcoxon Rank Sum
test was performed with a threshold of p,.05 for significance
(using software provided at http://www.socr.ucla.edu/htmls/ana/
TwoIndependentSampleWilcoxonRankSum_Analysis.html). As
this analysis is principally descriptive, no adjustment was made
for multiple comparisons. Post hoc exploration was conducting
comparing the proportion of articles that generated $25 and $40
citations during the first 3 complete calendar years post-
publication, and significance for this was tested by Fisher’s exact
test (using software provided at http://www.openepi.com/Menu/
OpenEpiMenu.htm). The threshold of $25 characterizes articles
that are at least in the top quartile.
Results
In both 2000 and 2005, 12 regular issues of JCP were published
in each year. In 2000, 14 supplements were published, 9 of which
were designated as CME activities, with instructions, posttest,
registration and evaluation. In 2005, 10 supplements were
published, with 7 containing information on obtaining CME
credit. Figure 1 describes the number of individual PDF files
available electronically and the number of eligible articles included
in each cohort. Table 1 contains the citation counts for each
cohort, including mean 6 SD, median, and full range, for all years
where data is available. The interquartile range for the citation
counts 3 years post-publication were 4–20, 8–20, 8–23, and 8–20,
for the 2000 parent journal, 2000 supplements, 2005 parent
journal, and 2005 supplements, respectively.
Table 2 provides the results of the comparisons between the 4
cohorts.
Table 3 provides the proportion of articles that generated $25
and $40 citations during the first 3 complete calendar years post-
publication.
Discussion
Articles published in supplements in JCP are often cited when
compared to the parent journal. The median number of citations
from the 2000 cohorts appears to favor the supplements; although
5 years later there were no differences in the median number of
citations in the 2005 cohorts. When adjusting for time by limiting
the citation counts to the subsequent 3 calendar years after
publication, the median number of citations for both the parent
journal and the supplements were higher for the 2005 cohorts
compared to the 2000 cohorts, but with a greater relative increase
noted for the parent journal. The proportions of highly cited
articles (articles that have generated at least 25 or 40 citations)
Citability of Articles
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Table 1. Citation counts for articles contained in the Journal of Clinical Psychiatry and supplements, 2000 and 2005.
Year Citations per Article
2000 Cohort 2005 Cohort
Parent Journal (N=114 in
12 issues)
Supplements (N=90 in 14
issues)
Parent Journal (N=190
in 12 issues)
Supplements (N=52 in
10 issues)
median, range mean 6 SD median, range mean 6 SD median, range mean 6 SD median, range mean 6 SD
2000 0, 0–4 0.526.96 0, 0–6 0.8361.17 ––––
2001 2, 0–21 3.0563.25 3, 0–14 3.4062.99 ––––
2002 3.5, 0–50 5.2966.59 6, 0–20 5.8063.78 ––––
2003 3.5, 0–50 5.8966.76 6, 0–16 6.0463.97 ––––
2004 4, 0–37 5.2766.10 4.5, 0–28 5.6364.68 ––––
2005 3, 0–32 5.2665.89 5, 0–33 5.2764.62 0, 0–11 0.7361.53 0, 0–5 0.7961.13
2006 3, 0–26 4.6864.55 4, 0–26 4.3464.00 3, 0–25 4.8264.70 3, 0–16 3.6463.06
2007 3, 0–23 4.0664.46 3. 0–31 4.4664.60 5, 0–40 6.5266.49 4, 0–19 6.0064.64
2008 2, 0–24 4.0064.80 3, 0–39 4.1265.36 5, 0–30 6.7266.06 5, 0–42 6.5466.33
2009
a 2, 0–12 2.4162.54 1.5, 0–18 2.3162.85 3, 0–25 4.1664.42 3, 0–38 3.8365.69
All years 27.5, 0–264 40.44639.33 39, 4–206 42.21629.62 16.5, 0–111 22.94619.80 16, 2–100 20.79616.55
3 years post-publication
b 10, 0–116 14.22615.42 14, 1–49 15.2468.86 13.5, 0–85 18.05615.44 13.5, 2–62 16.17611.78
aTo October 5, 2009.
b2001–2003 for the cohorts from 2000; 2006–2008 for the cohorts from 2005.
doi:10.1371/journal.pone.0009876.t001
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supplements although a numerically higher proportion was
consistently observed in favor of the parent journal for the 2005
cohort.
The mean number of citations per citable article shown in
table 1 can be viewed as a ‘‘citability index’’ and is similar in
concept to the journal impact factor [33]. As with the journal
impact factor, there is wide variability in citation rates for
individual articles no matter the overall citability index [34].
The ISI database used in this study does not include all possible
citation sources. For example, the Google Scholar database [35]
can yield higher numbers of citations [36]. However it is doubtful
that these additional sources would skew either towards citations to
the parent journal or to its supplements enough to make a
difference in the overall findings presented here.
A caveat is that the results of this bibliometric analysis of articles
from JCP may not be generalizable to other journals that
principally publish research reports and/or to those journals that
do not regularly issue supplements. In general, multi-specialty and
specialty journals can have diverse aims, scope, and editorial
standards. Not all supplements from all journals are financed by
pharmaceutical or medical device manufacturers. Some journals
may already have in place a rigorous peer-review process for their
supplements. This study should be replicated using another
journal which makes much use of supplements, perhaps in a field
of specialty other than psychiatry.
Citation counts by themselves may not be necessarily reflective
of the impact an article has on actual day-to-day clinical practice;
citations in the literature are done primarily by academics and not
ordinarily by community practitioners. Moreover, the number of
citations an article receives may not be representative of the
number of readers who have accessed the article. An article may
be clinically influential yet not often cited. Other metrics such as
number of downloads from a website, or the number of reprints
ordered by commercial interests, may provide additional infor-
mation regarding how many persons have actually obtained a
copy of the article (or supplement).
Whether or not citing articles from supplements is good practice
is not addressed by this analysis. Citation rates may not be related
to the quality of the cited articles. It is possible that the highly cited
articles, regardless of where they were published, may contain
information that other authors may have found useful to support
their arguments. It is also possible that an article is cited to identify
methodological shortcomings and to show how the citing study
intends to rectify those limitations. A limitation of this study is that
the individual quality of each cited report was not assessed, and no
distinction was made between reports of randomized controlled
trials, other types of original reports, and reviews. The contents of
the supplements were not further scrutinized regarding funding
source or potential biases in the articles themselves. There is some
published work regarding quality of articles in journal supplements
versus the parent publication, but all of it predates this decade
[25,37,38]. Also unexplored are whether articles published in
supplements are preferentially cited by other articles that have
been sponsored in some way.
Of additional interest is the impact of self-citation (i.e. citing
one’s previous publication in a new publication). Self-citation was
reported in a bibliometric analysis of articles about diabetes
mellitus in 170 clinical journals published in 2000 [39]. Nearly
one-fifth of all citations were author self-citations [39]. However in
that report, original articles had twice the proportion of author
self-citations compared with review articles. Assuming this
observation is generalizable to the JCP, because supplements
usually contain reviews and the parent journal usually contains a
high proportion of research reports, the impact of author self-
citation on differential citation rates between supplement and
parent may be difficult to interpret. Another issue is that of journal
self-citation, i.e. when publications in a journal cite previous
publications in the same journal [40]. Journal self-citation can
have a positive effect on a journal’s impact factor [41], and can
potentially affect citation rates to articles in supplements and their
parent journal.
Unaddressed in this analysis is the issue of ghost authorship
[42,43] and ghost management [44] of supplements. ‘‘Ghost
writing’’ was described in 1934 [45] and in that report the author
recommended that the assistance of medical writers be acknowl-
edged. Several decades later it is apparent that this acknowledge-
Table 2. Nonparametric analyses of citation counts for the
first 3 complete calendar years post-publication
ab .
Comparison z-score p-value
Parent journal vs supplements, 2000 cohorts 2.309 .02
Parent journal vs supplements, 2005 cohorts .145 .88
Parent journal, 2000 vs 2005 2.679 .007
Supplements, 2000 vs 2005 .074 .94
a2001–2003 for the cohorts from 2000; 2006–2008 for the cohorts from 2005.
bAs calculated at http://www.socr.ucla.edu/htmls/ana/
TwoIndependentSampleWilcoxonRankSum_Analysis.html; 2-tail p-value
provided.
doi:10.1371/journal.pone.0009876.t002
Table 3. Proportion of articles that have generated $25 and $40 citations during the first 3 complete calendar years post-
publication
a.
Category Proportion
2000 Cohort 2005 Cohort
Parent Journal (N=114
in 12 issues)
Supplements (N=90
in 14 issues) p-value b
Parent Journal (N=190
in 12 issues)
Supplements (N=52
in 10 issues) p-value b
n % n% n% n %
$25 citations 14 12.3% 13 14.4% 0.80 45 23.7% 8 15.4% .27
$40 citations 4 3.5% 1 1.1% 0.53 20 10.5% 2 3.8% .21
a2001–2003 for the cohorts from 2000; 2006–2008 for the cohorts from 2005.
bFisher’s exact test (as calculated at http://www.openepi.com/Menu/OpenEpiMenu.htm); 2-tail p-value provided.
doi:10.1371/journal.pone.0009876.t003
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fertile ground for this behavior, given the different degree of
editorial scrutiny applied to supplements compared to their parent
journals.
Conclusions
Articles published in JCP supplements are robustly cited, with
many cited more often than many articles published in the parent
journal. Thus articles in supplements may be quite influential in
guiding clinical and research practice, as well as shaping critical
thinking. However, articles in supplements are not subject to the
same rigor of peer review as the parent journal and because they
are printed under the sponsorship of commercial interests, they
may be perceived as less than objective. A reasonable step to help
improve this perception would be to ensure that supplements are
peer-reviewed in the same way as regular articles in the parent
journal.
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